
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Latest articles from Renal and Urology News Overactive Bladder Clinical Trials</title>
        <link>http://www.renalandurologynews.com</link>
        <description>Latest articles from Renal and Urology News Overactive Bladder Clinical Trials</description>
        <itunes:author>RUN</itunes:author>
        <itunes:subtitle>Overactive Bladder Clinical Trials</itunes:subtitle>
        <itunes:summary>Ongoing clinical trials focusing on overactive bladder.</itunes:summary>
        <itunes:owner>
            <itunes:name>Overactive Bladder Clinical Trials</itunes:name>
            <itunes:email>custserv@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/210/RUN-logo_mobilev2_52428.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug</title>
          <description>A look at the following clinical trial: Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug.</description>
          <link>http://www.renalandurologynews.com/post-treatment-novmalized-urodynamiz-findings-as-the-golden-standard-of-objective-cure-for-female-overactive-bladder-patients-receiving-antimuscarinic-drug/article/278360/</link>
          <pubDate>Mon, 31 Dec 2012 15:32:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug.</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Use of Percutaneous Tibial Nerve Stimulation With Solifenacin or Placebo to Treat Refractory Overactive Bladder</title>
          <description>A look at the following clinical trial: Use of Percutaneous Tibial Nerve Stimulation With Solifenacin or Placebo to Treat Refractory Overactive Bladder.</description>
          <link>http://www.renalandurologynews.com/use-of-percutaneous-tibial-nerve-stimulation-with-solifenacin-or-placebo-to-treat-refractory-overactive-bladder/article/278359/</link>
          <pubDate>Mon, 31 Dec 2012 15:29:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Use of Percutaneous Tibial Nerve Stimulation With Solifenacin or Placebo to Treat Refractory Overactive Bladder.</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Anticholinergic Therapy for Overactive Bladder in Parkinson&apos;s Disease</title>
          <description>A look at the following clinical trial: Anticholinergic Therapy for Overactive Bladder in Parkinson&apos;s Disease.</description>
          <link>http://www.renalandurologynews.com/anticholinergic-therapy-for-overactive-bladder-in-parkinsons-disease/article/278358/</link>
          <pubDate>Mon, 31 Dec 2012 15:27:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Anticholinergic Therapy for Overactive Bladder in Parkinson&apos;s Disease.</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Are Previously Treated With Another Medicine But Were Not Satisfied With That Treatment (BEYOND)</title>
          <description>A look at the following clinical trial: A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Are Previously Treated With Another Medicine But Were Not Satisfied With That Treatment (BEYOND).</description>
          <link>http://www.renalandurologynews.com/a-study-to-evaluate-the-efficacy-and-safety-of-mirabegron-compared-to-solifenacin-in-patients-with-overactive-bladder-who-are-previously-treated-with-another-medicine-but-were-not-satisfied-with-that-treatment-beyond/article/270013/</link>
          <pubDate>Sat, 27 Oct 2012 17:52:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Are Previously Treated With Another Medicine But Were Not Satisfied With That Treatment (BEYOND).</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder</title>
          <description>A look at the following clinical trial: Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder.</description>
          <link>http://www.renalandurologynews.com/unilateral-versus-bilateral-neuromodulation-tests-in-the-treatment-of-refractory-idiopathic-overactive-bladder/article/270011/</link>
          <pubDate>Sat, 27 Oct 2012 17:48:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder.</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Bacterial Genomic Sequencing in Overactive Bladder</title>
          <description>A look at the following clinical trial: Bacterial Genomic Sequencing in Overactive Bladder.</description>
          <link>http://www.renalandurologynews.com/bacterial-genomic-sequencing-in-overactive-bladder/article/262092/</link>
          <pubDate>Mon, 03 Sep 2012 17:59:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Bacterial Genomic Sequencing in Overactive Bladder.</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder Syndrome</title>
          <description>A look at the following clinical trial: Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder Syndrome.</description>
          <link>http://www.renalandurologynews.com/different-injection-number-of-the-same-dose-of-botulinum-toxin-a-on-overactive-bladder-syndrome/article/262091/</link>
          <pubDate>Mon, 03 Sep 2012 17:57:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder Syndrome.</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate</title>
          <description>A look at the following clinical trial: Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate.</description>
          <link>http://www.renalandurologynews.com/trial-of-percutaneous-tibial-nerve-stimulation-ptns-versus-ptns-and-fesoterodine-fumarate/article/244796/</link>
          <pubDate>Tue, 01 May 2012 18:05:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate.</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Efficacy and Safety of Gabapentin in Treating Overactive Bladder (OAB)</title>
          <description>A look at the following clinical trial: Efficacy and Safety of Gabapentin in Treating Overactive Bladder (OAB).</description>
          <link>http://www.renalandurologynews.com/efficacy-and-safety-of-gabapentin-in-treating-overactive-bladder-oab/article/244795/</link>
          <pubDate>Tue, 01 May 2012 18:01:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Efficacy and Safety of Gabapentin in Treating Overactive Bladder (OAB).</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Premarin Versus Toviaz for Treatment of Overactive Bladder</title>
          <description>A look at the following clinical trial: Premarin Versus Toviaz for Treatment of Overactive Bladder.</description>
          <link>http://www.renalandurologynews.com/premarin-versus-toviaz-for-treatment-of-overactive-bladder/article/244794/</link>
          <pubDate>Tue, 01 May 2012 17:59:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Premarin Versus Toviaz for Treatment of Overactive Bladder.</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Painless Laser Therapy for Overactive Bladder (PLTOAB)</title>
          <description>A look at the following clinical trial: Painless Laser Therapy for Overactive Bladder (PLTOAB).</description>
          <link>http://www.renalandurologynews.com/painless-laser-therapy-for-overactive-bladder-pltoab/article/237793/</link>
          <pubDate>Sun, 01 Apr 2012 18:33:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Painless Laser Therapy for Overactive Bladder (PLTOAB).</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>A Study to Investigate How Effective and Safe Solifenacin Liquid Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug (LION)</title>
          <description>A look at the following clinical trial: A Study to Investigate How Effective and Safe Solifenacin Liquid Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug (LION).</description>
          <link>http://www.renalandurologynews.com/a-study-to-investigate-how-effective-and-safe-solifenacin-liquid-suspension-is-in-treating-childrenadolescents-aged-5-to-less-than-18-years-with-symptoms-of-overactive-bladder-oab-compared-to-a-non-active-drug-lion/article/237792/</link>
          <pubDate>Sun, 01 Apr 2012 18:31:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: A Study to Investigate How Effective and Safe Solifenacin Liquid Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug (LION).</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Study of Overactive Bladder in Women With Prolapse (SOAP)</title>
          <description>A look at the following clinical trial: Study of Overactive Bladder in Women With Prolapse (SOAP).</description>
          <link>http://www.renalandurologynews.com/study-of-overactive-bladder-in-women-with-prolapse-soap/article/237791/</link>
          <pubDate>Sun, 01 Apr 2012 18:27:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Study of Overactive Bladder in Women With Prolapse (SOAP).</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>An Exploratory Study to Investigate Bladder Contractions in the Storage Phase and Related Bladder Sensations in Healthy Females and Females With Overactive Bladder (OAB) Using High Resolution and Conventional Urodynamics</title>
          <description>A look at the following clinical trial: An Exploratory Study to Investigate Bladder Contractions in the Storage Phase and Related Bladder Sensations in Healthy Females and Females With Overactive Bladder (OAB) Using High Resolution and Conventional Urodynamics.</description>
          <link>http://www.renalandurologynews.com/an-exploratory-study-to-investigate-bladder-contractions-in-the-storage-phase-and-related-bladder-sensations-in-healthy-females-and-females-with-overactive-bladder-oab-using-high-resolution-and-conventional-urodynamics/article/232689/</link>
          <pubDate>Thu, 01 Mar 2012 11:00:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: An Exploratory Study to Investigate Bladder Contractions in the Storage Phase and Related Bladder Sensations in Healthy Females and Females With Overactive Bladder (OAB) Using High Resolution and Conventional Urodynamics.</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder</title>
          <description>A look at the following clinical trial: Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder.</description>
          <link>http://www.renalandurologynews.com/interventions-to-enhance-medication-persistence-and-compliance-in-patients-with-overactive-bladder/article/232688/</link>
          <pubDate>Thu, 01 Mar 2012 11:00:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder.</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Vaginal Electrical Stimulation Versus Neuromodulation</title>
          <description>A look at the following clinical trial: Vaginal Electrical Stimulation Versus Neuromodulation.</description>
          <link>http://www.renalandurologynews.com/vaginal-electrical-stimulation-versus-neuromodulation/article/232687/</link>
          <pubDate>Thu, 01 Mar 2012 11:00:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Vaginal Electrical Stimulation Versus Neuromodulation.</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients</title>
          <description>A look at the following clinical trial: Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients.</description>
          <link>http://www.renalandurologynews.com/urinary-nerve-growth-factor-ngf-prostaglandin-e2-pge2and-adenosine-triphosphate-atp-potential-biomarkers-in-overactive-bladder-patients/article/224346/</link>
          <pubDate>Sun, 01 Jan 2012 20:06:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients.</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Therapy of the Overactive Bladder Syndrome (TOBS)</title>
          <description>A look at the following clinical trial: Therapy of the Overactive Bladder Syndrome (TOBS).</description>
          <link>http://www.renalandurologynews.com/therapy-of-the-overactive-bladder-syndrome-tobs/article/224345/</link>
          <pubDate>Sun, 01 Jan 2012 20:04:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Therapy of the Overactive Bladder Syndrome (TOBS).</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>A Study of the Pharmacokinetics and Pharmacodynamics of MK4618 in Women With Overactive Bladder (MK-4618-004)</title>
          <description>A look at the following clinical trial: A Study of the Pharmacokinetics and Pharmacodynamics of MK4618 in Women With Overactive Bladder (MK-4618-004).</description>
          <link>http://www.renalandurologynews.com/a-study-of-the-pharmacokinetics-and-pharmacodynamics-of-mk4618-in-women-with-overactive-bladder-mk-4618-004/article/224344/</link>
          <pubDate>Sun, 01 Jan 2012 20:03:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: A Study of the Pharmacokinetics and Pharmacodynamics of MK4618 in Women With Overactive Bladder (MK-4618-004).</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Evaluation of Autonomic System Before and After Anticholinergic Treatment in Women With Overactive Bladder</title>
          <description>A look at the following clinical trial: Evaluation of Autonomic System Before and After Anticholinergic Treatment in Women With Overactive Bladder.</description>
          <link>http://www.renalandurologynews.com/evaluation-of-autonomic-system-before-and-after-anticholinergic-treatment-in-women-with-overactive-bladder/article/224342/</link>
          <pubDate>Sun, 01 Jan 2012 20:00:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Evaluation of Autonomic System Before and After Anticholinergic Treatment in Women With Overactive Bladder.</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo Administered as Oral Daily Dose for Three Months in Patients Suffering From Overactive Bladder</title>
          <description>A look at the following clinical trial: A Prospective, Multi-center, Placebo-controlled, Randomized, Double-blind, Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo Administered as Oral Daily Dose for Three Months in Patients Suffering From Overactive Bladder.</description>
          <link>http://www.renalandurologynews.com/a-phase-2-study-to-compare-the-efficacy-and-tolerability-of-tarafenacin-02-mg-and-tarafenacin-04-mg-to-placebo-administered-as-oral-daily-dose-for-three-months-in-patients-suffering-from-overactive-bladder/article/220156/</link>
          <pubDate>Thu, 01 Dec 2011 15:42:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: A Prospective, Multi-center, Placebo-controlled, Randomized, Double-blind, Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo Administered as Oral Daily Dose for Three Months in Patients Suffering From Overactive Bladder.</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder</title>
          <description>A look at the following clinical trial: Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder.</description>
          <link>http://www.renalandurologynews.com/safety-and-efficacy-study-of-botulinum-toxin-type-a-for-the-treatment-of-neurogenic-overactive-bladder/article/220155/</link>
          <pubDate>Thu, 01 Dec 2011 15:40:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder.</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder</title>
          <description>A look at the following clinical trial: Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder.</description>
          <link>http://www.renalandurologynews.com/post-marketing-surveillance-of-fesoterodine-in-filipino-patients-with-over-active-bladder/article/217369/</link>
          <pubDate>Tue, 22 Nov 2011 16:10:14 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder.</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)</title>
          <description>A look at the following clinical trial: Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH).</description>
          <link>http://www.renalandurologynews.com/combination-treatment-with-doxazosin-plus-tolterodinesr-2-mg-versus-4mg-in-men-with-an-overactive-bladder-oab-and-benign-prostatic-hyperplasia-bph/article/213435/</link>
          <pubDate>Mon, 03 Oct 2011 16:14:27 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH).</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Effects and Safety of Liposome Encapsulated Botulinum Toxin A for Overactive Bladder Syndrome</title>
          <description>A look at the following clinical trial: Effects and Safety of Liposome Encapsulated Botulinum Toxin A for Overactive Bladder Syndrome.</description>
          <link>http://www.renalandurologynews.com/effects-and-safety-of-liposome-encapsulated-botulinum-toxin-a-for-overactive-bladder-syndrome/article/213427/</link>
          <pubDate>Mon, 03 Oct 2011 15:59:00 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Effects and Safety of Liposome Encapsulated Botulinum Toxin A for Overactive Bladder Syndrome.</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder</title>
          <description>A look at the following clinical trial: Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder.</description>
          <link>http://www.renalandurologynews.com/comparison-of-solifenacin-and-oxybutynin-in-the-treatment-of-overactive-bladder/article/213276/</link>
          <pubDate>Fri, 30 Sep 2011 18:55:54 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder.</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Comparative Urine Proteomic Studies of Overactive Bladder in Humans</title>
          <description>A look at the following clinical trial: Comparative Urine Proteomic Studies of Overactive Bladder in Humans.</description>
          <link>http://www.renalandurologynews.com/comparative-urine-proteomic-studies-of-overactive-bladder-in-humans/article/213274/</link>
          <pubDate>Fri, 30 Sep 2011 18:53:39 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Comparative Urine Proteomic Studies of Overactive Bladder in Humans.</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Grouptraining for Overactive Bladder in Adults</title>
          <description>A look at the following clinical trial: Grouptraining for Overactive Bladder in Adults.</description>
          <link>http://www.renalandurologynews.com/grouptraining-for-overactive-bladder-in-adults/article/207488/</link>
          <pubDate>Thu, 14 Jul 2011 18:36:01 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Grouptraining for Overactive Bladder in Adults.</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson&apos;s Disease (URGE-PD)</title>
          <description>A look at the following clinical trial: Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson&apos;s Disease (URGE-PD).</description>
          <link>http://www.renalandurologynews.com/solifenacin-succinate-vesicare-for-the-treatment-of-overactive-bladder-in-parkinsons-disease-urge-pd/article/199122/</link>
          <pubDate>Thu, 24 Mar 2011 20:53:51 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson&apos;s Disease (URGE-PD).</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
        <item>
          <title>Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder</title>
          <description>A look at the following clinical trial: Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder.</description>
          <link>http://www.renalandurologynews.com/comparison-of-caffeine-reduction-and-anticholinergic-medications-for-treatment-of-overactive-bladder/article/129266/</link>
          <pubDate>Mon, 23 Mar 2009 17:30:44 GMT</pubDate>
          <itunes:summary>A look at the following clinical trial: Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder.</itunes:summary>
          <itunes:author>RUN</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  